The global dental biomaterials market is a highly regulated market. The dental biomaterials market is mainly driven by increased investments, funds and grants by government bodies worldwide, precipitous growth anticipated for plastic surgery and wound healing applications, growing number of elderly people, technological advancements, and changing lifestyles.
The report analyzes the market in terms of technology devices into 4 segments, such as dental bone graft & substitutes, dental membranes, dental implants, and tissue regeneration materials.
Incessant rise in the number of collaborations, conferences, and research-related activities are also propelling the growth of the dental biomaterials market globally. Immunological and inflammatory reactions, stringent regulatory systems, issue of fatigue, wear, and reimbursement concerns are the major restraints of the dental biomaterials market. The global dental biomaterial market witnesses a plethora of growth opportunities. Biomaterials find wide application in field of dental market as a result of the novel developments of biomaterials for wound healing and tissue engineering, coupled with the colossal pool of dental patients worldwide. The burning issues affecting the growth of the dental biomaterials market are challenges to tissue engineering and the effects on suppliers from the Biomaterials Access Assurance Act.
The global dental biomaterials market is dominated by North America. The growth of the market is expected to be driven by increasing government investments in biomaterial sector, reimbursements offered by the Centers for Medicare and Medicaid Services (CMS), and the rising aging population, who are the main consumers of dental biomaterials.
Some of the key players in the global dental biomaterials market include Heraeus Dental LLC., Straumann, Nobel Biocare Holdings AG., and Aap Implantate AG, among others. The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options:
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:
Product Analysis:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of dental applications of biomaterials
- Country-specific patient pool of dental applications of biomaterials (pattern analysis)
Procedure Volume Data
- Biomaterials used in dental procedures performed annually in each country, tracked till sub-segment level
- The number of dental procedures performed in each country
Surgeons'/Physicians' Perception Analysis:
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Pattern analysis of usage of biomaterials by physicians
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on plastic surgery data
Brand/Product Perception Matrix:
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and dental clinics, reimbursement scenario, diagnosis rate, treatment rate, and healthcare expenditure).
